Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy

NCT ID: NCT05768971

Last Updated: 2023-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-06

Study Completion Date

2014-11-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate differences of the bowel wall thickness visible in conventional ultrasound and bowel perfusion using quantitative Contrast-Enhanced Ultrasound in patients with Crohn´s disease in comparison with healthy controls and patients with food allergy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study and potential risks, all participants giving written consent will undergo conventional transabdominal ultrasound and Contrast-Enhanced Ultrasound of the bowel wall with measurement of the bowel wall thickness. In addition a continuous video sequence during Contrast-Enhanced Ultrasound is recorded and perfusion kinetics from the video clips are analyzed using a specific quantification software.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crohn Disease Food Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Crohn´s disease

Ultrasound in patients with proven active Crohn´s disease scheduled for therapy with anti tumor necrosis factor alpha antibodies

No interventions assigned to this group

Patients with Food allergy

Patients with proven food allergy

Mild diet

Intervention Type OTHER

Provocative diet

Intervention Type OTHER

Healthy controls

Healthy, food-tolerant volunteers without any abdominal complaint

Mild diet

Intervention Type OTHER

Provocative diet

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mild diet

Intervention Type OTHER

Provocative diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 18
* Endoscopically and histologically confirmed active Crohn´s disease or
* Previously proven food allergy (double-blind or single-blind food challenge tests with placebo controls previously before the sonographic examination, increased blood and / or intestinal Immunoglobulin E levels, elevated methylhistamine values under provocation and with reproducible reactions during food challenge procedures) or
* Healthy individuals without abdominal complaints

Exclusion Criteria

* Age under 18
* Intolerance of the ultrasound contrast agent SonoVue
* Refusal of participation in the study
* Pregnancy or breast-feeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Friedrich-Alexander-Universität Erlangen-Nürnberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dane Wildner

Principal Investigator - Deputy Head of Ultrasound Department, Department of Internal Medicine 1, Universitätsklinikum Erlangen

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dane Wildner, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Medicine 1, Divison of ultrasound medicine, University Hospital Erlangen

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DCEUS_CD_NMA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultrasound Evaluation of Crohn's Disease
NCT03235180 TERMINATED PHASE4
WAter Preparation in Crohn's Disease's Imagery
NCT06690632 NOT_YET_RECRUITING NA